Curevac N.V. (NQ: CVAC )

102.61 +6.96 (+7.28%)

Official Closing Price Updated: 7:59 PM EDT, Apr 14, 2021 Add to My Watchlist

Price and Volume

Volume	1,503,700
Open	100.00
Bid (Size)	102.80 (4)
Ask (Size)	104.00 (2)
Prev. Close	95.65
Today's Range	99.91 - 104.49
52wk Range	36.15 - 151.80
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021

April 09, 2021

CureVac's COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant (South African Variant) in Preclinical Challenge Study

March 23, 2021

Performance

YTD	+20.58%	+20.58%
1 Month	+14.19%	+14.19%
3 Month	+4.44%	+4.44%
6 Month	+90.30%	+90.30%
1 Year	+83.56%	+83.56%

More News

CureVac Expands CVnCoV Covid-19 Vaccine Candidate Clinical Trial Analyses to Include Phase 2b/3 Variant Specification and Efficacy Secondary Endpoint to Phase 2a

March 22, 2021

UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots

Today 9:13 EDT

South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report

April 12, 2021

Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC

April 08, 2021

Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots

April 07, 2021

EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report

March 31, 2021

Curevac N V Getting Closer To Key Technical Measure

Today 3:00 EDT

Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents

March 31, 2021

CureVac Taps Celonic For COVID-19 Vaccine Production

March 30, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.